Sunshine Biopharma Stock Price, News & Analysis
SBFMW
NASDAQ
Company Description
Sunshine Biopharma Inc. (SBFMW) is a pharmaceutical company based in Montreal, Quebec, Canada. They specialize in developing life-saving medicines in areas such as oncology and antivirals. The company's proprietary drug development program includes K1.1 mRNA for liver cancer, SBFM-PL4, a PLpro protease inhibitor for SARS Coronavirus infections, and Adva-27a for pancreatic cancer. With reportable segments in Generic Pharmaceuticals and OTC Products, Sunshine Biopharma primarily generates revenue from the Generic Pharmaceuticals segment.
Stock Performance
$—
0.00%
0.00
Last updated:
-5.35 %
Performance 1 year
$0.0
Market Cap
2.6M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Sunshine Biopharma.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Sunshine Biopharma (SBFMW)?
The current stock price of Sunshine Biopharma (SBFMW) is $0.21 as of April 29, 2025.
What is Sunshine Biopharma Inc. known for?
Sunshine Biopharma is known for developing life-saving medicines in therapeutic areas like oncology and antivirals.
What are some of the core projects of Sunshine Biopharma Inc.?
Sunshine Biopharma is working on projects like K1.1 mRNA for liver cancer, SBFM-PL4 for SARS Coronavirus infections, and Adva-27a for pancreatic cancer.
How does Sunshine Biopharma Inc. generate revenue?
Sunshine Biopharma primarily generates revenue from its Generic Pharmaceuticals segment.
Where is Sunshine Biopharma Inc. located?
Sunshine Biopharma Inc. is based in Montreal, Quebec, Canada.
Who can be contacted for more information about Sunshine Biopharma Inc.?
You can contact CFO Camille Sebaaly at 514-814-0464 or camille.sebaaly@sunshinebiopharma.com for more information.
What are the two reportable segments of Sunshine Biopharma Inc.?
Sunshine Biopharma Inc.'s reportable segments are Generic Pharmaceuticals and OTC Products.
What is the focus of Sunshine Biopharma Inc.'s drug development program?
Sunshine Biopharma's drug development program focuses on developing life-saving medicines in therapeutic areas like oncology and antivirals.
What is the significance of K1.1 mRNA in Sunshine Biopharma Inc.'s projects?
K1.1 mRNA is targeted for liver cancer and is a key project in Sunshine Biopharma's drug development program.
How is SBFM-PL4 relevant to Sunshine Biopharma Inc.'s work?
SBFM-PL4 is a PLpro protease inhibitor developed by Sunshine Biopharma for SARS Coronavirus infections.
What is Adva-27a and its role in Sunshine Biopharma Inc.'s projects?
Adva-27a is a drug developed by Sunshine Biopharma for pancreatic cancer and is a significant part of their drug development program.